Restricting the forced early applications to the Social Security disability benefits program is a common-sense reform and ...

DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...

VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...

PIL Logistics has launched a new logo and refreshed brand identity which signals a closer collaboration with its parent ...